This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Urokinase 3D Structures
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *Urokinase | + | *Urokinase' Domains - N terminal 21-163; Kringle 69-153; catalytic 179-431 |
| - | **[[2i9a]] - hUK Hc N terminal | + | **[[2i9a]] - hUK Hc N terminal - human<br /> |
**[[1urk]] - hUK Hc N terminal – NMR<br /> | **[[1urk]] - hUK Hc N terminal – NMR<br /> | ||
| - | **[[1kdu]] – hUK kringle domain | + | **[[1kdu]] – hUK kringle domain - NMR<br /> |
| - | **[[4dva]] – hUK catalytic domain | + | **[[4dva]] – hUK catalytic domain <br /> |
**[[4xsk]] - hUK catalytic domain (mutant) <br /> | **[[4xsk]] - hUK catalytic domain (mutant) <br /> | ||
**[[5lhs]] - UK catalytic domain (mutant) - mouse<br /> | **[[5lhs]] - UK catalytic domain (mutant) - mouse<br /> | ||
| - | *Urokinase catalytic domain | + | *Urokinase catalytic domain complex with inhibitors |
| - | **[[4fu7]], [[4fu8]], [[4fu9]], [[4fub]], [[5xg4]], [[5wxs]] - hUK + inhibitor<br /> | + | **[[1c5w]], [[1c5x]], [[1c5y]], [[1c5z]], [[1lmw]], [[3ig6]], [[4fu7]], [[4fu8]], [[4fu9]], [[4fub]], [[5xg4]], [[5wxs]] - hUK + inhibitor<br /> |
| - | **[[1f92]], [[1sc8]], [[1vj9]], [[1vja]], [[2o8t]], [[2o8u]], [[2o8w]], [[4h42]], [[4mnv]],[[5wxt]] - hUK (mutant) + inhibitor<br /> | + | **[[1f92]], [[1gi7]], [[1gi8]], [[1gi9]], [[1gj7]], [[1gj8]], [[1gj9]], [[1gja]], [[1gjb]], [[1gjc]], [[1gjd]], [[1o3p]], [[1o5a]], [[1o5b]], [[1o5c]], [[1sc8]], [[1vj9]], [[1vja]], [[2o8t]], [[2o8u]], [[2o8w]], [[3kgp]], [[3khv]], [[3kid]], [[3mhw]], [[3mwi]], [[3ox7]], [[3oy5]], [[3oy6]], [[4h42]], [[4mnv]],[[5wxt]] - hUK (mutant) + inhibitor<br /> |
**[[1fv9]] – hUK (mutant) + benzimidazole derivative <br /> | **[[1fv9]] – hUK (mutant) + benzimidazole derivative <br /> | ||
**[[5yc6]], [[5yc7]] - hUK (mutant) + benzylamine derivative<br /> | **[[5yc6]], [[5yc7]] - hUK (mutant) + benzylamine derivative<br /> | ||
| Line 26: | Line 26: | ||
**[[2vin]], [[2vio]], [[2vip]], [[2viq]], [[2viv]], [[2viw]] - hUK (mutant) + mexiletine derivative<br /> | **[[2vin]], [[2vio]], [[2vip]], [[2viq]], [[2viv]], [[2viw]] - hUK (mutant) + mexiletine derivative<br /> | ||
**[[3qn7]], [[4jk5]], [[4jk6]], [[4x1n]], [[4x1q]], [[4x1r]], [[4x1s]], [[4x0w]], [[4x1p]], [[4zhl]], [[4zhm]], [[4zkn]], [[4zko]], [[4zkr]], [[4zks]] - hUK (mutant) + peptide inhibitor<br /> | **[[3qn7]], [[4jk5]], [[4jk6]], [[4x1n]], [[4x1q]], [[4x1r]], [[4x1s]], [[4x0w]], [[4x1p]], [[4zhl]], [[4zhm]], [[4zkn]], [[4zko]], [[4zkr]], [[4zks]] - hUK (mutant) + peptide inhibitor<br /> | ||
| - | **[[4mnw]], [[4mnx]], [[4mny]], [[4os1]], [[4os2]], [[4os4]], [[4os5]], [[4os6]], [[4os7]] - hUK (mutant) + bicyclic peptide <br /> | + | **[[2nwn]], [[3m61]], [[4gly]], [[4mnw]], [[4mnx]], [[4mny]], [[4os1]], [[4os2]], [[4os4]], [[4os5]], [[4os6]], [[4os7]] - hUK (mutant) + bicyclic peptide <br /> |
**[[2vnt]], [[2r2w]] - hUK + guanidine derivative<br /> | **[[2vnt]], [[2r2w]] - hUK + guanidine derivative<br /> | ||
**[[5xg4]] - hUK + quercetin<br /> | **[[5xg4]] - hUK + quercetin<br /> | ||
| Line 35: | Line 35: | ||
**[[5wxp]]- hUK + UPAIN-2-3-W3F<br /> | **[[5wxp]]- hUK + UPAIN-2-3-W3F<br /> | ||
**[[5wxr]]- hUK + UPAIN-2-4-W3F<br /> | **[[5wxr]]- hUK + UPAIN-2-4-W3F<br /> | ||
| - | |||
| - | *Urokinase C terminal complex with inhibitors | ||
| - | |||
| - | **[[3kgp]] – hUK Hc C terminal (mutant) + benzoic acid derivative<br /> | ||
| - | **[[3khv]] - hUK Hc C terminal (mutant) + methanol derivative<br /> | ||
| - | **[[3mwi]] - hUK Hc C terminal (mutant) + amidine derivative<br /> | ||
| - | **[[3ox7]], [[3oy5]], [[3oy6]] - hUK Hc C terminal (mutant) + peptide inhibitor<br /> | ||
| - | **[[3kid]], [[3mhw]] - hUK Hc C terminal (mutant) + aminobenzothiazole derivative<br /> | ||
| - | **[[2nwn]], [[4gly]] - hUK Hc C terminal + cyclic peptide<br /> | ||
| - | **[[3m61]] - hUK Hc C terminal (mutant) + cyclic peptide | ||
| - | |||
| - | *Urokinase short chain + catalytic domain complex with inhibitors | ||
| - | |||
| - | **[[1lmw]] – hUK A+B catalytic domain + EGRCMK<br /> | ||
| - | **[[1c5w]], [[1c5x]], [[1c5y]], [[1c5z]] - hUK A+B chain catalytic domain + carboxamidine derivative<br /> | ||
| - | **[[1gi7]], [[1gi8]], [[1gi9]], [[1gj7]], [[1gj8]], [[1gj9]], [[1gja]], [[1gjb]], [[1gjc]], [[1gjd]] - hUK A+B chain catalytic domain (mutant) + carboxamidine derivative<br /> | ||
| - | **[[1o3p]], [[1o5a]], [[1o5b]], [[1o5c]] - hUK A+B chain catalytic domain (mutant) + benzenolate derivative<br /> | ||
| - | **[[3ig6]] – hUK A+B chain catalytic domain + inhibitor<br /> | ||
*Urokinase complex with protein | *Urokinase complex with protein | ||
| Line 61: | Line 43: | ||
**[[3laq]], [[3u73]] - hUK Hc N terminal + UK receptor<br /> | **[[3laq]], [[3u73]] - hUK Hc N terminal + UK receptor<br /> | ||
**[[2i9b]] - hUK Hc N terminal + UK receptor (mutant)<br /> | **[[2i9b]] - hUK Hc N terminal + UK receptor (mutant)<br /> | ||
| - | **[[3pb1]] - hUK Hc | + | **[[3pb1]] - hUK Hc catalytic domain (mutant) + UK inhibitor<br /> |
**[[4dw2]] - hUK B chain catalytic domain + antibody<br /> | **[[4dw2]] - hUK B chain catalytic domain + antibody<br /> | ||
**[[5hgg]] - hUK catalytic domain (mutant) + antibody<br /> | **[[5hgg]] - hUK catalytic domain (mutant) + antibody<br /> | ||
Revision as of 08:50, 9 January 2021
3D Structures of urokinase
Updated on 09-January-2021 - For a general description of the protein see Urokinase
